Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
2023年5月25日 - 5:05AM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that aims
to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the following investor conferences.
- William Blair 43rd Annual Growth Stock Conference in Chicago,
ILPresenting on Wednesday, June 7th at 8:40 a.m. Central Time
- Goldman Sachs 44th Annual Global Healthcare Conference in Dana
Point, CAFireside chat on Monday, June 12th at 4:00 p.m. Pacific
Time
Interested parties may access live and archived
webcasts of the sessions on the “Investors” section of the company
website at: www.adaptivebiotech.com.
About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed. We apply our platform to partner with
biopharmaceutical companies, inform drug development, and develop
clinical diagnostics across our two business areas: Minimal
Residual Disease (MRD) and Immune Medicine. Our commercial products
and clinical pipeline enable the diagnosis, monitoring, and
treatment of diseases such as cancer, autoimmune disorders, and
infectious diseases. Our goal is to develop and commercialize
immune-driven clinical products tailored to each individual
patient.
ADAPTIVE MEDIAErica Jones,
Associate Corporate Communications
Director206-279-2423media@adaptivebiotech.com
ADAPTIVE INVESTORSKarina
Calzadilla, Vice President, Investor
Relations201-396-1687investors@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 4 2024 まで 5 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 5 2023 まで 5 2024